Met Life Investment Management, LLC Codexis, Inc. Transaction History
Met Life Investment Management, LLC
- $20.1 Billion
- Q3 2025
A detailed history of Met Life Investment Management, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 35,281 shares of CDXS stock, worth $58,213. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,281
Previous 50,349
29.93%
Holding current value
$58,213
Previous $122,000
29.51%
% of portfolio
0.0%
Previous 0.0%
Shares
45 transactions
Others Institutions Holding CDXS
# of Institutions
144Shares Held
68.4MCall Options Held
42KPut Options Held
31.8K-
Opaleye Management Inc. Boston, MA12.8MShares$21.1 Million5.2% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$11.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.67MShares$7.71 Million0.0% of portfolio
-
Abrdn PLC4.09MShares$6.75 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.07MShares$6.71 Million0.0% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $108M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...